File(s) under permanent embargo
A phase I/II study of LDE225, a smoothened (Smo) antagonist, in pediatric patients with recurrent medulloblastoma (MB) or other solid tumors
conference contribution
posted on 2012-01-01, 00:00 authored by B Geoerger, I Aerts, M Casanova, J Chisholm, D Hargrave, S Leary, David Ashley, E Bouffet, T Macdonald, E Hurh, J Dey, S Kalambakas, D Amakye, M KieranA phase I/II study of LDE225, a smoothened (Smo) antagonist, in pediatric patients with recurrent medulloblastoma (MB) or other solid tumors
History
Event
American Society of Clinical Oncology.Meeting (2012 : Chicago, Ill.)Pagination
1 - 1Publisher
American Society of Clinical OncologyLocation
Chicago, Ill.Place of publication
Alexandria, Va.Start date
2012-06-01End date
2012-06-05Language
engPublication classification
E2.1 Full written paper - non-refereed / Abstract reviewedCopyright notice
2012, American Society of Clinical OncologyTitle of proceedings
ASCO 2012: Collaborating to conquer cancer : Proceedings of the American Society of Clinical Oncology 2012 meetingUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC